Industry

CLEVELAND, Ohio–(BUSINESS WIRE)–$ATHX–Athersys, Inc. (Nasdaq: ATHX) today announced the Company’s slate of director candidates for its 2022 Annual Meeting of Stockholders being held on Thursday, July 28, 2022, at 8:30 a.m. ET. As previously announced, in connection with the Company’s cost-cutting and restructuring initiatives, the Board of Directors approved reducing its size from ten to … [Read more…]

Survey of 12,850 people demonstrates the significant contribution of over-65s; report makes three-point recommendations to further improve intergenerational solidarity. NYON, Switzerland–(BUSINESS WIRE)–Edwards Lifesciences today published ‘Unifying Generations: Building the Pathway to Intergenerational Solidarity’ – a report, based on a survey of 12,850 Europeans across generations, that demonstrates the need to change perceptions of the value … [Read more…]

Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design Collaboration leverages Iktos’ capabilities in machine learning and AI and Zealand expertise in peptide drug discovery PARIS–(BUSINESS WIRE)–Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), … [Read more…]

Pharma and healthcare experts Dr Donna Lockhart and Greg Whelan join with newly created roles of Head of Medicines and Group Sales Director as business progresses LONDON–(BUSINESS WIRE)–#appointments–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant … [Read more…]

EpiSwitch CiRT® is a first-of-its-kind precision medicine test that predicts a patient’s likely response to widely used Immune Checkpoint Inhibitor (ICI) therapies. The test has shown high sensitivity (93%), specificity (82%), accuracy (85%), and NPV (93%) across 15 cancer indications where ICI treatments are approved. The simple clinical blood test is now also available to … [Read more…]

BETHESDA, Md.–(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development candidate. Researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (“JNCASR”), in India, conducted about 10 years of research and discovery work on NMI … [Read more…]

News Summary:      Companies collaborate to promote development of bioanalytical skills with joint opening of the ASEAN Academy for Bioanalysis in South Korea      Training academy will help enhance regional scientific competitiveness and quality of pharmaceutical research and testing      Academy trainees will contribute towards meeting increasing demand for lower cost, generic drugs in southeast … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today objected to efforts by the World Health Organization (WHO) to rein in Africa Centres for Disease Control and Prevention’s (CDC) autonomy in declaring regional health emergencies and other emergency public health powers – a move that is paternalistic and runs counter to the principles of self-determination enshrined in … [Read more…]

Listing to accelerate expansion of HLI clinics in key US and International locations to provide precision longevity medicine care to clients worldwide Strategic owner Freedom Acquisition I (NYSE: FACT), led by Tidjane Thiam, Adam Gishen, and Edward Zeng to retain significant stake HLI clinics demonstrate attractive returns and payback profile Transaction values combined company at … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) expressed disappointment today with the decision of the World Trade Organization’s Ministerial Conference, which fell short of substantively addressing intellectual property rights roadblocks to COVID-19 vaccine access in developing countries. What has been heralded by some wealthy countries as a breakthrough compromise may indeed prove to be a smokescreen … [Read more…]